Europe Molecular Diagnostics Market Forecast to 2030 - Regional Analysis - by Disease Area (Oncology, Infectious Disease, Genetic Testing, Cardiac Diseases, Immune System Disorders, and Others), Technology (Polymerase Chain Reaction, Isothermal Nucleic Acid Amplification Technology, DNA Sequencing & Next-Generation Sequencing, DNA Microarrays, In-Situ Hybridization, and Others), Product and Services (Assays & Kits, Instruments, and Services & Software), and End User (Hospitals & Clinics, Diagnostic Laboratories, Research & Academic Institutes, and Others)

TIPRE00026715 | Pages: 134 | Medical Device | Jan 2024 | Type: Regional | Status: Published

The Europe molecular diagnostics market is expected to grow from US$ 4,592.54 million in 2022 to US$ 11,225.77 million by 2030. It is estimated to grow at a CAGR of 11.8% from 2022 to 2030.

Surging Prevalence of Associated Diseases Fuels Europe Molecular Diagnostics Market

Molecular diagnostics procedures can be employed in the detection of a wide range of conditions such as oncologic diseases, infectious diseases, cardiac diseases, and immune system disorders; they can also be used in genetic testing using genetic material such as DNA and RNA for the diagnosis of different diseases. Cancer is one of the leading causes of death worldwide. The early detection of the disease can help prevent death among the patients. According to the data published by the UK.GOV on November 22, 2021, the infection rate of COVID-19 was ~422.7 per 100,000 population.  Thus, the rising prevalence of target diseases fuels the molecular diagnostics market growth.

Europe Molecular Diagnostics Market Overview

The European molecular diagnostics market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. The region holds a significant share of the global molecular diagnostics market and is expected to register a robust CAGR during 2022–2030. The market growth in Europe is attributed to growing life science research and an increase in government investment in testing infectious diseases.

Chronic diseases such as chronic obstructive pulmonary disease (COPD), diabetes, cancer, and arthritis can be life-threatening if left untreated. For instance, chronic lymphocytic leukemia (CLL) is the most common type of leukemia in Germany. According to the Deutsches Ärzteblatt, the prevalence of CLL in Germany stands at ~6 cases per 100,000; nearly 850 women and 1,000 men die from CLL every year.

Europe Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Million)

Europe Molecular Diagnostics Market Segmentation 

The Europe molecular diagnostics market is segmented into disease area, technology, product and services, end user, and country.

Based on disease area, the Europe molecular diagnostics market is segmented into infectious disease, oncology, genetic testing, cardiac diseases, immune system disorders, and others. The infectious disease segment registered the largest Europe molecular diagnostics market share in 2022.

Based on technology, the Europe molecular diagnostics market is segmented into polymerase chain reaction (PCR), in situ hybridization, isothermal nucleic acid amplification technology (INAAT), DNA sequencing and next-generation sequencing (NGS), DNA microarrays, and others. The polymerase chain reaction (PCR) segment registered the largest Europe molecular diagnostics market share in 2022. The polymerase chain reaction (PCR) is further sub segmented into RT-PCR, qPCR, multiplex PCR, and others.

Based on product and services, the Europe molecular diagnostics market is segmented into assays and kits, instruments, and services and software. The assays and kits segment registered the largest Europe molecular diagnostics market share in 2022.

Based on end users, the Europe molecular diagnostics market is segmented into diagnostic laboratories, hospitals and clinics, research and academic institutes, and others. The diagnostic laboratories segment held the largest Europe molecular diagnostics market share in 2022.

Based on country, the Europe molecular diagnostics market has been categorized into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe molecular diagnostics market in 2022.  

Abbott Laboratories, Agilent Technologies Inc, Thermo Fisher Scientific Inc, F. Hoffmann-La Roche Ltd, Qiagen NV, bioMerieux SA, Illumina Inc, Danaher, Siemens Healthineers AG, and Novartis AG are some of the leading companies operating in the Europe molecular diagnostics market.    

1.           Introduction

1.1       The Insight Partners Research Report Guidance

1.2       Market Segmentation

2.           Executive Summary

2.1       Key Insights

3.           Research Methodology

3.1       Coverage

3.2       Secondary Research

3.3       Primary Research

4.           Europe Molecular Diagnostics Market Landscape

4.1       Overview

4.2       PEST Analysis

4.2.1         Europe PEST Analysis

5.           Europe Molecular Diagnostics Market - Key Industry Dynamics

5.1       Key Market Drivers:

5.1.1         Development of New Products and Increase in Demand for Point-of-Care Testing

5.1.2         Surging Prevalence of Associated Diseases

5.2       Market Restraints

5.2.1         Limitations Associated with Molecular Testing

5.3       Market Opportunities

5.3.1         Advancements in Molecular Diagnostics Technologies

5.4       Future Trends

5.4.1         Molecular Diagnostics in Personalized Medicine

5.5       Impact Analysis:

6.           Molecular Diagnostics Market - Europe Market Analysis

6.1       Europe Molecular Diagnostics Market Revenue (US$ Mn), 2022 – 2030

7.           Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 – by Disease Area

7.1       Overview

7.2       Europe Molecular Diagnostics Market Revenue Share, by Disease Area 2022 & 2030 (%)

7.3       Oncology

7.3.1         Overview

7.3.2         Oncology: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

7.4       Infectious Disease

7.4.1         Overview

7.4.2         Infectious Disease: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

7.5       Genetic Testing

7.5.1         Overview

7.5.2         Genetic Testing: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

7.6       Cardiac Diseases

7.6.1         Overview

7.6.2         Cardiac Diseases: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

7.7       Immune System Disorders

7.7.1         Overview

7.7.2         Immune System Disorders: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030  (US$ Million)

7.8       Others

7.8.1         Overview

7.8.2         Others: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

8.           Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 – by Technology

8.1       Overview

8.2       Europe Molecular Diagnostics Market Revenue Share, by Technology 2022 & 2030 (%)

8.3       Polymerase Chain Reaction

8.3.1         Overview

8.3.2         PCR: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

8.3.2.1           RT-PCR

8.3.2.1.1          Overview

8.3.3         RT-PCR: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

8.3.3.1           qPCR

8.3.3.1.1          Overview

8.3.4         qPCR: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

8.3.4.1           Multiplex PCR

8.3.4.1.1          Overview

8.3.5         Multiplex PCR: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

8.3.5.1           Others

8.3.5.1.1          Overview

8.3.6         Others: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

8.4       Isothermal Nucleic Acid Amplification Technology (INAAT)

8.4.1         Overview

8.4.2         Isothermal Nucleic Acid Amplification Technology (INAAT): Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

8.5       DNA Sequencing and Next-Generation Sequencing (NGS)

8.5.1         Overview

8.5.2         DNA Sequencing and Next-Generation Sequencing (NGS): Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

8.6       DNA Microarrays

8.6.1         Overview

8.6.2         DNA Microarrays: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

8.7       In-Situ Hybridization (ISH)

8.7.1         Overview

8.7.2         In-Situ Hybridization (ISH): Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

8.8       Others

8.8.1         Overview

8.8.2         Others: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

9.           Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 – by Product and Services

9.1       Overview

9.2       Europe Molecular Diagnostics Market Revenue Share, by Product and Services 2022 & 2030 (%)

9.3       Assays and Kits

9.3.1         Overview

9.3.2         Assays and Kits: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

9.4       Instruments

9.4.1         Overview

9.4.2         Instruments: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

9.5       Services and Software

9.5.1         Overview

9.5.2         Services and Software: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.        Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 – by End User

10.1     Overview

10.2     Europe Molecular Diagnostics Market Revenue Share, by End User 2022 & 2030 (%)

10.3     Hospitals and Clinics

10.3.1       Overview

10.3.2       Hospitals and Clinics: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.4     Diagnostics Laboratories

10.4.1       Overview

10.4.2       Diagnostics Laboratories: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.5     Research and Academic Institutes

10.5.1       Overview

10.5.2       Research and Academic Institutes: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.6     Others

10.6.1       Overview

10.6.2       Others: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

11.        Europe Molecular Diagnostics Market - Country Analysis

11.1     Europe Molecular Diagnostics Market, Revenue and Forecast to 2030

11.1.1       Overview

11.1.1.1         Europe Molecular Diagnostics Market by Country

11.1.2       Germany

11.1.2.1         Overview

11.1.3       Germany: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)

11.1.4       Germany: Molecular Diagnostics Market, by Disease Area

11.1.5       Germany: Molecular Diagnostics Market, by Technology

11.1.5.1         Germany: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)

11.1.6       Germany: Molecular Diagnostics Market, by Product and Services

11.1.7       Germany: Molecular Diagnostics Market, by End User

11.1.8       UK

11.1.8.1         Overview

11.1.9       UK : Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)

11.1.10    UK: Molecular Diagnostics Market, by Disease Area

11.1.11    UK:  Molecular Diagnostics Market, by Technology

11.1.11.1      UK:  Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)

11.1.12    UK:  Molecular Diagnostics Market, by Product and Services

11.1.13    UK:  Molecular Diagnostics Market, by End User

11.1.14    France

11.1.14.1      Overview

11.1.15    France:  Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)

11.1.16    France: Molecular Diagnostics Market, by Disease Area

11.1.17    France:  Molecular Diagnostics Market, by Technology

11.1.17.1      France:  Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)

11.1.18    France:  Molecular Diagnostics Market, by Product and Services

11.1.19    France:  Molecular Diagnostics Market, by End User

11.1.20    Italy

11.1.20.1      Overview

11.1.21    Italy: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)

11.1.22    Italy: Molecular Diagnostics Market, by Disease Area

11.1.23    Italy:  Molecular Diagnostics Market, by Technology

11.1.23.1      Italy: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)

11.1.24    Italy: Molecular Diagnostics Market, by Product and Services

11.1.25    Italy: Molecular Diagnostics Market, by End User

11.1.26    Spain

11.1.26.1      Overview

11.1.27    Spain: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)

11.1.28    Spain: Molecular Diagnostics Market, by Disease Area

11.1.29    Spain: Molecular Diagnostics Market, by Technology

11.1.29.1      Spain: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)

11.1.29.1.1     Spain:  Molecular Diagnostics Market, by Product and Services

11.1.30    Spain:  Molecular Diagnostics Market, by End User

11.1.31    Rest of Europe

11.1.31.1      Overview

11.1.32    Rest of Europe:  Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)

11.1.33    Rest of Europe: Molecular Diagnostics Market, by Disease Area

11.1.34    Rest of Europe: Molecular Diagnostics Market, by Technology

11.1.34.1      Rest of Europe: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)

11.1.35    Rest of Europe: Molecular Diagnostics Market, by Product and Services

11.1.36    Rest of Europe: Molecular Diagnostics Market, by End User

12.        Europe Molecular Diagnostics Market Industry Landscape

12.1     Overview

12.2     Growth Strategies Done by the Companies in the Market (%)

12.3     Organic Developments

12.3.1       Overview

12.4     Inorganic Developments

12.4.1       Overview

13.        Europe Molecular Diagnostics Market, Key Company Profiles

13.1     Abbott Laboratories

13.1.1       Key Facts

13.1.2       Business Description

13.1.3       Products and Services

13.1.4       Financial Overview

13.1.5       SWOT Analysis

13.1.6       Key Developments

13.2     Agilent Technologies Inc

13.2.1       Key Facts

13.2.2       Business Description

13.2.3       Products and Services

13.2.4       Financial Overview

13.2.5       SWOT Analysis

13.2.6       Key Developments

13.3     Thermo Fisher Scientific Inc

13.3.1       Key Facts

13.3.2       Business Description

13.3.3       Products and Services

13.3.4       Financial Overview

13.3.5       SWOT Analysis

13.3.6       Key Developments

13.4     F. Hoffmann-La Roche Ltd

13.4.1       Key Facts

13.4.2       Business Description

13.4.3       Products and Services

13.4.4       Financial Overview

13.4.5       SWOT Analysis

13.4.6       Key Developments

13.5     Qiagen NV

13.5.1       Key Facts

13.5.2       Business Description

13.5.3       Products and Services

13.5.4       Financial Overview

13.5.5       SWOT Analysis

13.5.6       Key Developments

13.6     bioMerieux SA

13.6.1       Key Facts

13.6.2       Business Description

13.6.3       Products and Services

13.6.4       Financial Overview

13.6.5       SWOT Analysis

13.6.6       Key Developments

13.7     Illumina Inc

13.7.1       Key Facts

13.7.2       Business Description

13.7.3       Products and Services

13.7.4       Financial Overview

13.7.5       SWOT Analysis

13.7.6       Key Developments

13.8     Danaher

13.8.1       Key Facts

13.8.2       Business Description

13.8.3       Products and Services

13.8.4       Financial Overview

13.8.5       SWOT Analysis

13.8.6       Key Developments

13.9     Siemens Healthineers AG

13.9.1       Key Facts

13.9.2       Business Description

13.9.3       Products and Services

13.9.4       Financial Overview

13.9.5       SWOT Analysis

13.9.6       Key Developments

13.10  Novartis AG

13.10.1    Key Facts

13.10.2    Business Description

13.10.3    Products and Services

13.10.4    Financial Overview

13.10.5    SWOT Analysis

13.10.6    Key Developments

14.        Appendix

14.1     About Us

14.2     Glossary of Terms

 

 

 

List of Tables

Table 1.              Europe Molecular Diagnostics Market Segmentation

Table 2.              Germany: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Disease Area

Table 3.              Germany: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology

Table 4.              Germany: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR)

Table 5.              Germany: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services

Table 6.              Germany: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – End User

Table 7.              UK:  Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area

Table 8.              UK:  Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology

Table 9.              UK:  Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR)

Table 10.           UK:  Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services

Table 11.           UK:  Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – End User

Table 12.           France: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area

Table 13.           France:  Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology

Table 14.           France: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR)

Table 15.           France:  Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services

Table 16.           France: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – End User

Table 17.           Italy:  Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area

Table 18.           Italy: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology

Table 19.           Italy:  Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR)

Table 20.           Italy: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services

Table 21.           Italy: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – End User

Table 22.           Spain: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area

Table 23.           Spain: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology

Table 24.           Spain: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR)

Table 25.           Spain: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services

Table 26.           Spain:  Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – End User

Table 27.           Rest of Europe: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area

Table 28.           Rest of Europe: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology

Table 29.           Rest of Europe: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR)

Table 30.           Rest of Europe: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services

Table 31.           Rest of Europe: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – End User

Table 32.           Organic Developments Done By Companies

Table 33.           Inorganic Developments Done By Companies

Table 34.           Glossary of Terms, Molecular Diagnostics Market

 

 

List of Figures

Figure 1.            Europe - PEST Analysis

Figure 2.            Europe Molecular Diagnostics Market - Key Industry Dynamics

Figure 3.            Impact Analysis of Drivers and Restraints

Figure 4.            Europe Molecular Diagnostics Market Revenue (US$ Mn), 2022 – 2030

Figure 5.            Europe Molecular Diagnostics Market Revenue Share, by Disease Area 2022 & 2030 (%)

Figure 6.            Oncology: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 7.            Infectious Disease: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 8.            Genetic Testing: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 9.            Cardiac Diseases: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 10.          Immune System Disorders: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 11.          Others: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 12.          Europe Molecular Diagnostics Market Revenue Share, by Technology 2022 & 2030 (%)

Figure 13.          PCR: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 14.          RT-PCR: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 15.          qPCR: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 16.          Multiplex PCR: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 17.          Others: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 18.          Isothermal Nucleic Acid Amplification Technology (INAAT): Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 19.          DNA Sequencing and Next-Generation Sequencing (NGS): Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 20.          DNA microarrays: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 21.          In-Situ Hybridization (ISH): Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 22.          Others: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 23.          Europe Molecular Diagnostics Market Revenue Share, by Product and Services 2022 & 2030 (%)

Figure 24.          Assays and Kits: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 25.          Instruments: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 26.          Services and Software: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 27.          Europe Molecular Diagnostics Market Revenue Share, by End User 2022 & 2030 (%)

Figure 28.          Hospitals and Clinics: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 29.          Ambulatory Surgical Centers: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 30.          Research and Academic Institutes: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 31.          Others: Europe Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 32.          Europe Molecular Diagnostics Market, By country, 2022 ($Mn)

Figure 33.          Europe Molecular Diagnostics Market, By Key Countries, 2022 And 2030 (%)

Figure 34.          Germany: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)

Figure 35.          UK:  Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)

Figure 36.          France: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)

Figure 37.          Italy:  Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)

Figure 38.          Spain: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)

Figure 39.          Rest of Europe: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)

Figure 40.          Growth Strategies Done by the Companies in the Market (%)

 

  1. Abbott Laboratories
  2. Agilent Technologies Inc
  3. bioMerieux SA
  4. Danaher
  5. F. Hoffmann-La Roche Ltd
  6. Illumina Inc
  7. Novartis AG
  8. Qiagen NV
  9. Siemens Healthineers AG
  10. Thermo Fisher Scientific Inc
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe molecular diagnostics market.   
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the Europe molecular diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the molecular diagnostics market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution  
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3550
$2840
Site License
$4550
$3640
Enterprise License
$5550
$4440